Authors:
KEANE TE
ELGALLEY RES
SUN C
PETROS JA
DILLAHEY D
GOMAA A
GRAHAM SD
MCGUIRE WP
Citation: Te. Keane et al., CAMPTOTHECIN ANALOGUES CISPLATIN - AN EFFECTIVE TREATMENT OF ADVANCEDBLADDER-CANCER IN A PRECLINICAL IN-VIVO MODEL SYSTEM/, The Journal of urology, 160(1), 1998, pp. 252-256
Authors:
KEANE TE
HARRIS WB
SUN C
KARR J
PETROS JA
GRAHAM SD
Citation: Te. Keane et al., IRENOTECAN (CPT-11) IN ADVANCED RENAL-CELL CARCINOMA - RESULTS OF A MULTI DOSE STUDY DEFINING THE MINIMAL EFFECTIVE DOSE USING A MODEL OF ADVANCED RENAL-CELL CARCINOMA (RCC), The Journal of urology, 159(5), 1998, pp. 751-751
Authors:
HAMBLIN C
SALT JS
GRAHAM SD
HOPWOOD K
WADEEVANS AM
Citation: C. Hamblin et al., BLUETONGUE VIRUS SEROTYPES 1 AND 3 INFECTION IN POLL DORSET SHEEP, Australian Veterinary Journal, 76(9), 1998, pp. 622-629
Authors:
WESTHUYZEN J
GRAHAM SD
RASIAH RL
SALTISSI D
Citation: J. Westhuyzen et al., SIMPLIFIED SIZING OF LOW-DENSITY-LIPOPROTEIN USING POLYACRYLAMIDE GRADIENT GEL-ELECTROPHORESIS OF PLASMA, European journal of clinical chemistry and clinical biochemistry, 35(1), 1997, pp. 17-19
Citation: H. Sanders et Sd. Graham, COMPARISON OF 4 AUTOMATED PROSTATE-SPECIFIC ANTIGEN ASSAYS FOR DETECTION OF RECURRENCE AFTER RADICAL PROSTATECTOMY, Urology, 49(6), 1997, pp. 894-897
Authors:
LAFONTAINE PD
MIDDLEMAN BR
GRAHAM SD
SANDERS WH
Citation: Pd. Lafontaine et al., INCIDENCE OF GRANULOMATOUS PROSTATITIS AND ACID-FAST BACILLI AFTER INTRAVESICAL BCG THERAPY, Urology, 49(3), 1997, pp. 363-366
Authors:
TOWNSEND MF
SANDERS WH
NORTHWAY RO
GRAHAM SD
Citation: Mf. Townsend et al., BONE-FRACTURES ASSOCIATED WITH LUTEINIZING-HORMONE-RELEASING HORMONE AGONISTS USED IN THE TREATMENT OF PROSTATE CARCINOMA, Cancer, 79(3), 1997, pp. 545-550
Citation: Av. Panov et al., BIOENERGETIC PROPERTIES OF HUMAN PROSTATE-CANCER CELLS LINES, DU145, PC-3 AND LNCAP, AND FIBROSARCOMA HT1080C1 CELLS, Biophysical journal, 72(2), 1997, pp. 374-374
Authors:
WANG YC
ZHU LH
MCHUGH R
GRAHAM SD
HILLYER CD
DILLEHAY D
SELL KW
SELVARAJ P
Citation: Yc. Wang et al., INDUCTION OF AUTOLOGOUS TUMOR-SPECIFIC CYTOTOXIC T-LYMPHOCYTE ACTIVITY AGAINST A HUMAN RENAL-CARCINOMA CELL-LINE BY B7-1 (CD80) COSTIMULATION, Journal of immunotherapy with emphasis on tumor immunology, 19(1), 1996, pp. 1-8
Citation: Av. Panov et al., RESPIRATORY PROPERTIES OF 3 HUMAN PROSTATE-CANCER CELL-LINES, DU145, PC-3 AND LNCAP, AND HUMAN FIBROSARCOMA HT1080C1 CELLS, Molecular biology of the cell, 7, 1996, pp. 866-866
Authors:
WANG YC
ZHU LH
MCHUGH R
GRAHAM SD
HILLYER CD
DILLEHAY D
SELL KW
SELVARAJ P
Citation: Yc. Wang et al., EXPRESSION OF B7-1 BUT NOT ICAM-1, VCAM-1 OR LFA-3 RESULTS IN INDUCTION OF AUTOLOGOUS TUMOR-SPECIFIC CYTOTOXIC T-LYMPHOCYTE ACTIVITY IN A HUMAN RENAL-CARCINOMA MODEL, The FASEB journal, 10(6), 1996, pp. 2555-2555
Authors:
SHARIFI R
BRUSKEWITZ RC
GITTLEMAN MC
GRAHAM SD
HUDSON PB
STEIN B
Citation: R. Sharifi et al., LEUPROLIDE ACETATE 22.5 MG 12-WEEK DEPOT FORMULATION IN THE TREATMENTOF PATIENTS WITH ADVANCED PROSTATE-CANCER, Clinical therapeutics, 18(4), 1996, pp. 647-657
Authors:
SAROSDY MF
LOWE BA
SCHELLHAMMER PF
LAMM DL
GRAHAM SD
GROSSMAN HB
SEE WA
PEABODY JO
MOON TD
FLANIGAN RC
CRAWFORD ED
MORGANROTH J
Citation: Mf. Sarosdy et al., ORAL BROPIRIMINE IMMUNOTHERAPY OF CARCINOMA IN-SITU OF THE BLADDER - RESULTS OF A PHASE-II TRIAL, Urology, 48(1), 1996, pp. 21-27
Authors:
ELGALLEY RES
PETROS JA
SANDERS WH
KEANE TE
GALLOWAY NTM
COONER WH
GRAHAM SD
Citation: Res. Elgalley et al., NORMAL RANGE PROSTATE-SPECIFIC ANTIGEN VERSUS AGE-SPECIFIC PROSTATE-SPECIFIC ANTIGEN IN SCREENING PROSTATE ADENOCARCINOMA, Urology, 46(2), 1995, pp. 200-204
Citation: Sd. Graham, PROGNOSTIC FACTORS FOR SURVIVAL IN PATIENTS WITH METASTATIC RENAL-CANCER TREATED WITH BIOLOGICAL RESPONSE MODIFIERS - COMMENT, The Journal of urology, 154(1), 1995, pp. 40-40
Citation: Dr. Salomao et al., MICROVASCULAR INVASION IN PROSTATE-CANCER CORRELATES WITH PATHOLOGICAL STAGE, Archives of pathology and laboratory medicine, 119(11), 1995, pp. 1050-1054
Citation: J. Kalish et al., SERUM PSA ADJUSTED FOR VOLUME OF TRANSITION ZONE (PSAT) IS MORE ACCURATE THAN PSA ADJUSTED FOR TOTAL GLAND VOLUME (PSAD) IN DETECTING ADENOCARCINOMA OF THE PROSTATE, Urology, 43(5), 1994, pp. 601-606